AMENDED AND RESTATED ASSET PURCHASE AGREEMENTAsset Purchase Agreement • April 19th, 2019 • Pernix Therapeutics Holdings, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledApril 19th, 2019 Company Industry JurisdictionThis AMENDED AND RESTATED ASSET PURCHASE AGREEMENT, dated as of April 15, 2019 (this “Agreement“), is made by and among Pernix Therapeutics Holdings, Inc., a Maryland corporation (“Seller Parent“), Pernix Ireland Pain Designated Activity Company, a designated activity company incorporated under the laws of Ireland (formerly known as Pernix Ireland Pain Limited), each of the Sellers set forth on Annex A (Seller Parent together with the foregoing entities, each a “Seller“ and collectively, the “Sellers“) and Currax Holdings LLC (f/k/a Phoenix Top Holdings LLC), a Delaware limited liability company (the “Buyer“), and amends and restates the Asset Purchase Agreement, dated as of February 18, 2019, by and among the Sellers and the Buyer.
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • February 19th, 2019 • Pernix Therapeutics Holdings, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 19th, 2019 Company Industry JurisdictionASSET PURCHASE AGREEMENT, dated as of February 18, 2019 (this "Agreement"), by and among Pernix Therapeutics Holdings, Inc., a Maryland corporation ("Seller Parent"), Pernix Ireland Pain Designated Activity Company, a designated activity company incorporated under the laws of Ireland (formerly known as Pernix Ireland Pain Limited), each of the Sellers set forth on Annex A (Seller Parent together with the foregoing entities, each a "Seller" and collectively, the "Sellers") and Phoenix Top Holdings LLC, a Delaware limited liability company (the "Buyer").